Blog
RSS FeedPosted by Michael Wonder on 06 Aug 2023
Free the PrEP - over the counter access to HIV pre-exposure prophylaxis
5 August 2023 - Several barriers to access to preexposure prophylaxis for HIV could be alleviated by making it available over ...
Posted by Michael Wonder on 28 Jul 2023
FDA approves second over the counter naloxone nasal spray product
28 July 2023 - Today, the US FDA approved RiVive, 3 mg naloxone hydrochloride nasal spray for over the counter, non-prescription ...
Posted by Michael Wonder on 13 Jul 2023
FDA approves first non-prescription daily oral contraceptive
13 July 2023 - Today, the US FDA approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily ...
Posted by Michael Wonder on 17 Apr 2023
OTC naloxone is a baby step toward making the life-saving medication accessible
17 April 2023 - In an attempt to make naloxone more accessible amid the massive human toll of the opioid crisis, ...
Posted by Michael Wonder on 29 Mar 2023
FDA approves first over the counter naloxone nasal spray
29 March 2023 - Agency continues to take critical steps to reduce drug overdose deaths being driven primarily by illicit opioids. ...
Posted by Michael Wonder on 26 Oct 2022
US FDA delays panel meet on Perrigo's OTC birth control pill
26 October 2022 - The US FDA has delayed a meeting of its advisory panel to discuss Perrigo's over the ...
Posted by Michael Wonder on 01 Aug 2022
FDA may approve first OTC birth control pill In U.S.: more novel prescription to OTC switches could be on tap
1 August 2022 - The French drug maker HRA Pharma is seeking approval from the Food and Drug Administration (FDA) ...
Posted by Michael Wonder on 12 Jul 2022
FDA rule would facilitate prescription to OTC switches but nix a third class of drugs
12 July 2022 - After a decade long wait, the FDA finally issued a proposed rule in late June that ...
Posted by Michael Wonder on 11 Jul 2022
Perrigo's HRA Pharma submits application to FDA for first ever OTC birth control pill
11 July 2022 - Perrigo today announced that HRA Pharma, a Perrigo company, has submitted its application to the U.S. ...
Posted by Michael Wonder on 26 May 2022
Perrigo announces U.S. FDA approval for omeprazole magnesium delayed release mini capsules
26 May 2022 - Perrigo today announced that it has received final approval from the U.S. FDA for omeprazole magnesium delayed ...
Posted by Michael Wonder on 17 Jun 2021
FDA approves a nasal anti-histamine for non-prescription use
17 June 2021 - The U.S. FDA today approved a nasal antihistamine for nonprescription use through a process called a partial ...
Posted by Michael Wonder on 14 Feb 2020
FDA approves three drugs for non-prescription use through Rx-to-OTC switch process
14 February 2020 - The U.S. FDA today approved three drugs for nonprescription, or over-the-counter (OTC), use through a process called ...
Posted by Michael Wonder on 17 Jul 2018
Statement from FDA Commissioner on new efforts to empower consumers by advancing access to nonprescription drugs
17 July 2018 - At the FDA, we’re continuing to look at ways we can foster greater access to the ...
Posted by Michael Wonder on 08 Jul 2016
FDA approves Differin Gel 0.1% for over-the-counter use to treat acne
8 July 2016 - First retinoid approved for over-the-counter use. ...